Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recently we identified a novel 250 kDa protein in adipocytes that is a substrate for the insulin-activated
protein kinase
Akt. We refer to this protein as
AS250
for Akt substrate of 250 kDa.
AS250
has a predicted GTPase activating protein (GAP) domain at its carboxy terminus. This domain shows some homology to the GAP domains for Rheb at the carboxy terminus of the protein tuberin and for Rap1 in the protein Rap1 GAP. The present study further characterizes
AS250
. The cDNA sequence for human
AS250
is reported, and the sites that undergo phosphorylation upon insulin treatment of adipocytes have been identified by tandem mass spectrometry. We have found that in adipocytes
AS250
exists as a complex with a novel protein of 1484 amino acids known as KIAA1219. The complex of
AS250
with KIAA1219 is notably similar to the important regulatory complex of the protein tuberin with hamartin (the tuberous sclerosis complex), in the size of its subunits, the location of the GAP domain, and its phosphorylation by Akt. In an effort to detect the cellular role of the
AS250
/KIAA1219 complex, we generated 3T3-L1 adipocytes that largely lack
AS250
by shRNA knockdown and examined several insulin-dependent effects. The knockdown of
AS250
had no effect on insulin activation of the kinases, Akt, 70 kDa S6 kinase, or ERK1/2, or on insulin-stimulated actin bundling, and it had only a slight effect on insulin-stimulated GLUT4 translocation.
...
PMID:Adipocytes contain a novel complex similar to the tuberous sclerosis complex. 1649 Mar 46